These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 30138450)
21. Inactivation of mTor arrests bovine oocytes in the metaphase-I stage, despite reversible inhibition of 4E-BP1 phosphorylation. Mayer S; Wrenzycki C; Tomek W Mol Reprod Dev; 2014 Apr; 81(4):363-75. PubMed ID: 24459013 [TBL] [Abstract][Full Text] [Related]
22. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion. Chen L; Xu B; Liu L; Liu C; Luo Y; Chen X; Barzegar M; Chung J; Huang S Oncotarget; 2015 Mar; 6(9):7136-50. PubMed ID: 25762619 [TBL] [Abstract][Full Text] [Related]
23. The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes. Chiu H; Jackson LV; Oh KI; Mai A; Ronai ZA; Ruggero D; Fruman DA J Immunol; 2019 Jan; 202(2):579-590. PubMed ID: 30530594 [TBL] [Abstract][Full Text] [Related]
24. Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1. Wang J; Ye Q; Cao Y; Guo Y; Huang X; Mi W; Liu S; Wang C; Yang HS; Zhou BP; Evers BM; She QB Nat Commun; 2017 Dec; 8(1):2207. PubMed ID: 29263324 [TBL] [Abstract][Full Text] [Related]
25. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model. Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861 [TBL] [Abstract][Full Text] [Related]
26. Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size. Eguchi S; Tokunaga C; Hidayat S; Oshiro N; Yoshino K; Kikkawa U; Yonezawa K Genes Cells; 2006 Jul; 11(7):757-66. PubMed ID: 16824195 [TBL] [Abstract][Full Text] [Related]
27. Signalling to eIF4E in cancer. Siddiqui N; Sonenberg N Biochem Soc Trans; 2015 Oct; 43(5):763-72. PubMed ID: 26517881 [TBL] [Abstract][Full Text] [Related]
28. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663 [TBL] [Abstract][Full Text] [Related]
29. mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation. He K; Zheng X; Li M; Zhang L; Yu J Oncogene; 2016 Jan; 35(2):148-57. PubMed ID: 25867072 [TBL] [Abstract][Full Text] [Related]
30. mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio. Alain T; Sonenberg N; Topisirovic I Oncotarget; 2012 Dec; 3(12):1491-2. PubMed ID: 23455427 [No Abstract] [Full Text] [Related]
31. Clinical significance of mTOR and eIF4E expression in invasive ductal carcinoma. Hu A; Sun M; Yan D; Chen K Tumori; 2014; 100(5):541-6. PubMed ID: 25343550 [TBL] [Abstract][Full Text] [Related]
32. The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. D'Abronzo LS; Bose S; Crapuchettes ME; Beggs RE; Vinall RL; Tepper CG; Siddiqui S; Mudryj M; Melgoza FU; Durbin-Johnson BP; deVere White RW; Ghosh PM Oncogene; 2017 Nov; 36(46):6359-6373. PubMed ID: 28745319 [TBL] [Abstract][Full Text] [Related]
33. Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assembly. Frosi Y; Usher R; Lian DTG; Lane DP; Brown CJ BMC Biol; 2019 May; 17(1):40. PubMed ID: 31118010 [TBL] [Abstract][Full Text] [Related]
34. Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique. Batool A; Aashaq S; Andrabi KI Eur J Cell Biol; 2017 Jun; 96(4):325-336. PubMed ID: 28427795 [TBL] [Abstract][Full Text] [Related]
35. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Coleman LJ; Peter MB; Teall TJ; Brannan RA; Hanby AM; Honarpisheh H; Shaaban AM; Smith L; Speirs V; Verghese ET; McElwaine JN; Hughes TA Br J Cancer; 2009 May; 100(9):1393-9. PubMed ID: 19367274 [TBL] [Abstract][Full Text] [Related]
36. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway. Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281 [TBL] [Abstract][Full Text] [Related]
37. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis. Musa J; Orth MF; Dallmayer M; Baldauf M; Pardo C; Rotblat B; Kirchner T; Leprivier G; Grünewald TG Oncogene; 2016 Sep; 35(36):4675-88. PubMed ID: 26829052 [TBL] [Abstract][Full Text] [Related]
38. Increased milk protein synthesis in response to exogenous growth hormone is associated with changes in mechanistic (mammalian) target of rapamycin (mTOR)C1-dependent and independent cell signaling. Sciascia Q; Pacheco D; McCoard SA J Dairy Sci; 2013 Apr; 96(4):2327-2338. PubMed ID: 23462168 [TBL] [Abstract][Full Text] [Related]
39. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes. Kudchodkar SB; Yu Y; Maguire TG; Alwine JC Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14182-7. PubMed ID: 16959881 [TBL] [Abstract][Full Text] [Related]
40. A chemical genetic screen for mTOR pathway inhibitors based on 4E-BP-dependent nuclear accumulation of eIF4E. Livingstone M; Larsson O; Sukarieh R; Pelletier J; Sonenberg N Chem Biol; 2009 Dec; 16(12):1240-9. PubMed ID: 20064434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]